• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】21819

【品名】2-nitropropane

【CA登记号】79-46-9

【 分 子 式 】C3H7NO2

【 分 子 量 】89.09412

【元素组成】C 40.44% H 7.92% N 15.72% O 35.92%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(IV)

By reaction of 3-(2-methyl-2-aminopropyl)indole (I) and 2-(2,3-epoxypropoxy)benzonitrile (II) by heating at 120-40 C followed by a treatment with HCl in ethanol. The starting products are obtained as follows: 1) The reaction of 3-(dimethylaminomethyl)indole (III) with 2-nitropropane (IV) by means of KOH gives 3-(2-methyl-2-nitropropyl)indole (V), which is then reduced with hydrazine and Raney-Ni in ethanol to yield (I). 2) The reaction of 2-hydroxybenzonitrile (VI) with epichlorohydrin (VII) by means of piperidine affords 2-(3-chloro-2-hydroxypropoxy)benzonitrile (VIII), which is epoxidized again to (II) by treatment with NaOH in hot THF-water.

1 Kreighbaum, W.E.; et al.; Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity. J Med Chem 1980, 23, 3, 285-289.
2 Weetman, D.F.; Castaner, J.; Bucindolol Hydrochloride. Drugs Fut 1981, 6, 7, 405.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
10158 Piperidine 110-89-4 C5H11N 详情 详情
(I) 37566 2-(1H-indol-3-yl)-1,1-dimethylethylamine; 1-(1H-indol-3-yl)-2-methyl-2-propanamine C12H16N2 详情 详情
(II) 37567 2-(2-oxiranylmethoxy)benzonitrile C10H9NO2 详情 详情
(III) 37568 N,N-Dimethyl-1H-indole-3-methanamine;Gramine;N-(1H-indol-3-ylmethyl)-N,N-dimethylamine; 3-(dimethylaminomethyl)-indole[;]1H-indol-3-yl-N,N-dimethylmethanamine 87-52-5 C11H14N2 详情 详情
(IV) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(V) 37569 3-(2-methyl-2-nitropropyl)-1H-indole C12H14N2O2 详情 详情
(VI) 21990 2-hydroxybenzonitrile 611-20-1 C7H5NO 详情 详情
(VII) 10146 Epichlorohydrin; 2-(Chloromethyl)oxirane 106-89-8 C3H5ClO 详情 详情
(VIII) 37570 2-(3-chloro-2-hydroxypropoxy)benzonitrile C10H10ClNO2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

Condensation of aldehyde (I) with 2-nitropropane (II) using tert-butyldimethylsilyl chloride, tetrabutylammonium fluoride and triethylamine afforded a mixture of diastereomeric nitroaldol products (III). After separation by column chromatography, the desired isomer was protected as the tert-butyldimethylsilyl ether (IV). Deprotection of the benzoate ester of (IV) was carried out by reduction with diisobutylaluminum hydride to provide alcohol (V), which was then oxidized to the corresponding ketone (VI) with pyridinium chlorochromate. Wittig reaction of (VI) with phosphorane (VII) provided the bromomethylene compound (VIII).

1 Oshida, J.; et al.; Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3. Bioorg Med Chem Lett 1999, 9, 3, 381.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21818 (4S,7aR)-7a-methyl-1-[(1R)-1-methyl-4-oxobutyl]octahydro-1H-inden-4-yl benzoate C22H30O3 详情 详情
(II) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(III) 21820 (4S,7aR)-1-[(1R)-4-hydroxy-1,5-dimethyl-5-nitrohexyl]-7a-methyloctahydro-1H-inden-4-yl benzoate C25H37NO5 详情 详情
(IV) 21821 (4S,7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-yl benzoate C31H51NO5Si 详情 详情
(V) 21822 (4S,7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-ol C24H47NO4Si 详情 详情
(VI) 21823 (7aR)-1-((1R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-4H-inden-4-one C24H45NO4Si 详情 详情
(VIII) 21824 [[(1R,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl]oxy](tert-butyl)dimethylsilane; (1R,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl tert-butyl(dimethyl)silyl ether C25H46BrNO3Si 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Condensation of aldehyde (I) with 2-nitropropane (II) using tert-butyldimethylsilyl chloride, tetrabutylammonium fluoride and triethylamine afforded a mixture of diastereomeric nitroaldol products (III). After separation by column chromatography, the desired isomer was protected as the tert-butyldimethylsilyl ether (IV). Deprotection of the benzoate ester of (IV) was carried out by reduction with diisobutylaluminum hydride to provide alcohol (V), which was then oxidized to the corresponding ketone (VI) with pyridinium chlorochromate. Wittig reaction of (VI) with phosphorane (VII) provided the bromomethylene compound (VIII).

1 Oshida, J.; et al.; Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3. Bioorg Med Chem Lett 1999, 9, 3, 381.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21818 (4S,7aR)-7a-methyl-1-[(1R)-1-methyl-4-oxobutyl]octahydro-1H-inden-4-yl benzoate C22H30O3 详情 详情
(II) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(III) 21820 (4S,7aR)-1-[(1R)-4-hydroxy-1,5-dimethyl-5-nitrohexyl]-7a-methyloctahydro-1H-inden-4-yl benzoate C25H37NO5 详情 详情
(IV) 21828 (4S,7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-yl benzoate C31H51NO5Si 详情 详情
(V) 21829 (4S,7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-1H-inden-4-ol C24H47NO4Si 详情 详情
(VI) 21830 (7aR)-1-((1R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-1,5-dimethyl-5-nitrohexyl)-7a-methyloctahydro-4H-inden-4-one C24H45NO4Si 详情 详情
(VII) 21831 (bromomethyl)(triphenyl)phosphonium bromide 1034-49-7 C19H17Br2P 详情 详情
(VIII) 21832 (1S,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl tert-butyl(dimethyl)silyl ether; [[(1S,4R)-4-[(7aR)-4-[(E)-bromomethylidene]-7a-methyloctahydro-1H-inden-1-yl]-1-(1-methyl-1-nitroethyl)pentyl]oxy](tert-butyl)dimethylsilane C25H46BrNO3Si 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VII)

NPS-2143 can be obtained by coupling 2-chloro-6-[2(R)-oxiranylmethoxy]benzonitrile (I) with 1,1-dimethyl-2-(2-naphthyl)ethylamine (II) in ethanol at 50-60 C. Intermediates (I) and (II) can be obtained as follows: a) Treatment of 2-chloro-6-fluorobenzonitrile (III) with 18-crown-6 and potassium acetate in refluxing acetonitrile, followed by hydrolysis with NaOH in H2O provides 3-chloro-2-cyanophenol (IV), which is then condensed with 3-nitrobenzenesulfonic acid (2R)-2-oxiranylmethyl ester (V) in DMF by means of NaH to furnish 2-chloro-6-[2(R)-oxiranylmethoxy]benzonitrile (I). b) Treatment of 2-(aminomethyl)naphthalene (VI) with 2,4,6-triphenylpyrylium tetrafluoroborate in EtOH, followed by the reaction of the resulting compound dissolved in DMSO with the sodium salt obtained by treatment of 2-nitropropane (VII) with NaH in MeOH, gives the nitro derivative (VIII). Finally, reduction of the nitro group of (VIII) by hydrogenation over Ni Raney in EtOH yields 1,1,-dimethyl-2-(2-naphthyl)ethylamine (II).

2 Sheehan, D.; Del Mar, E.G.; Lago, M.A.; Southall, L.S.; Callahan, J.F.; Kotecha, N.R.; Thompson, M.; Barmore, R.M.; Keenan, R.M.; Van Wagenen, B.C. (GlaxoSmithKline Inc.; GlaxoSmithKline plc; NPS Pharmaceuticals, Inc.); Method of using calcilytic cpds.. US 6022894 .
1 del Fresno, M.; Doggrell, S.A.; Castaner, J.; NPS-2143. Drugs Fut 2002, 27, 2, 140.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
51708   C23H17BF4O 详情 详情
(I) 51706 2-chloro-6-[(2R)oxiranylmethoxy]benzonitrile C10H8ClNO2 详情 详情
(II) 51710 1,1-dimethyl-2-(2-naphthyl)ethylamine; 2-methyl-1-(2-naphthyl)-2-propanamine C14H17N 详情 详情
(III) 51704 2-Chloro-6-fluorobenzonitrile; 2-Fluoro-6-chlorobenzonitrile 668-45-1 C7H3ClFN 详情 详情
(IV) 51705 2-chloro-6-hydroxybenzonitrile C7H4ClNO 详情 详情
(V) 16259 (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate 115314-14-2 C9H9NO6S 详情 详情
(VI) 51707 2-naphthylmethanamine; 2-naphthylmethylamine C11H11N 详情 详情
(VII) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(VIII) 51709 2-(2-methyl-2-nitropropyl)naphthalene C14H15NO2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

By condensation of substituted nicotinamide (VI) with the carbazolyoxymethyl-oxirane (XII) in hot methanol/water. The intermediates the nicotinamide (VI) and the oxirane (XII) have been obtained as follows: 1.- Nicotinamide (VI): The reaction of 4-hydroxybenzyl alcohol (I) with 2-nitropropane (II) by means of potassium tert-butoxide in hot diglyme gives 4-(2-methyl-2-nitropropyl)phenol (III), which is reduced to the corresponding amino derivative (IV) with H2 over Pd/C in methanol/ethanol/acetic acid. Finally, this compound is condensed with 6-chloronicotinamide (V) by means of K2CO3 in dimethylacetamide/isooctane. 2.- Oxirane (XII): The reaction of phenylhydrazine (VII) with cyclohexane-1,3-dione (VIII) by means of NaHCO3 in isopropanol/water gives the monohydrazone (IX), which is cyclized with hotpolyphosphoric acid yielding the 4-hydroxycarbazole (X). Finally, this compound is condensed with the glycidyl 3-nitrophenylsulfonate (XI) by means of K2CO3 in refluxing acetone.

1 Crowell, T.A.; Evrard, D.A.; Jones, C.D.; Muehl, B.S.; Rito, C.J.; Shuker, A.J.; Thorpe, A.J.; Thrasher, K.J. (Eli Lilly and Company); Carbazole analogues as selective B3 adrenergic agonists. EP 0827746; WO 9809625 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 29474 4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol 4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol 623-05-2 C7H8O2 详情 详情
(II) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(III) 29475 4-(2-methyl-2-nitropropyl)phenol C10H13NO3 详情 详情
(IV) 29476 4-(2-amino-2-methylpropyl)phenol 51706-55-9 C10H15NO 详情 详情
(V) 29477 6-chloronicotinamide 6271-78-9 C6H5ClN2O 详情 详情
(VI) 29478 6-[4-(2-amino-2-methylpropyl)phenoxy]nicotinamide C16H19N3O2 详情 详情
(VII) 11818 Phenyl hydrazine; 1-Phenylhydrazine 100-63-0 C6H8N2 详情 详情
(VIII) 11244 1,3-Cyclohexanedione 504-02-9 C6H8O2 详情 详情
(IX) 29479 3-hydroxy-2-cyclohexen-1-one N-phenylhydrazone C12H14N2O 详情 详情
(X) 29480 4-Hydroxycarbazole; 9H-carbazol-4-ol 52602-39-8 C12H9NO 详情 详情
(XI) 16259 (2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate 115314-14-2 C9H9NO6S 详情 详情
(XII) 29481 9H-carbazol-4-yl (2S)oxiranylmethyl ether; 4-[(2S)oxiranylmethoxy]-9H-carbazole C15H13NO2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VI)

Preparation of the title compound has been reported by two procedures. Catalytic hydrogenation of benzofuran-4-carboxylic acid (I) over Pd/C afforded the dihydrobenzofuran (II). Carboxyl group reduction in (II) with LiAlH4 and further Swern oxidation of the resulting alcohol (III) furnished aldehyde (IV). Knoevenagel condensation of aldehyde (IV) with dimethyl malonate provided the benzylidenemalonate (V), which was converted to the key cyclopropane derivative (VII) upon treatment with 2-nitropropane (VI) and potassium tert-butoxide. Hydrolysis and decarboxylation of the malonate ester (VII) was performed using NaCN in hot DMSO to yield acid (VIIIa-b) as a diastereomeric mixture. Recrystallization of (VIIIa-b) from acetonitrile-water allowed the separation of the major (+/-)-trans-isomer, which was then resolved by preparative chiral HPLC. The desired (R,R)-isomer (IX) was finally coupled with guanidine (X) via activation with CDI

1 Ahmad, S.; et al.; Arylcyclopropanecarboxyl guanidines as novel, potent, and selective inhibitors of the sodium hydrogen exchanger isoform-1. J Med Chem 2001, 44, 20, 3302.
2 Wu, S.C.; Atwal, K.S.; Dugar, S.; Ahmad, S. (Bristol-Myers Squibb Co.); Acyl guanidine sodium/proton exchange inhibitors and method. EP 1041980; JP 2001527042; US 6011059; WO 9933460 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIIIa) 51881 (1R)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid C14H16O3 详情 详情
(VIIIb) 51882 (1S)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid C14H16O3 详情 详情
(I) 51875 1-benzofuran-4-carboxylic acid C9H6O3 详情 详情
(II) 51876 2,3-dihydro-1-benzofuran-4-carboxylic acid C9H8O3 详情 详情
(III) 51877 2,3-dihydro-1-benzofuran-4-ylmethanol C9H10O2 详情 详情
(IV) 51878 2,3-dihydro-1-benzofuran-4-carbaldehyde C9H8O2 详情 详情
(V) 51879 dimethyl 2-(2,3-dihydro-1-benzofuran-4-ylmethylene)malonate C14H14O5 详情 详情
(VI) 21819 2-nitropropane 79-46-9 C3H7NO2 详情 详情
(VII) 51880 dimethyl 3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethyl-1,1-cyclopropanedicarboxylate C17H20O5 详情 详情
(IX) 51883 (1R,3R)-3-(2,3-dihydro-1-benzofuran-4-yl)-2,2-dimethylcyclopropanecarboxylic acid C14H16O3 详情 详情
(X) 14790 Guanidine 113-00-8 CH5N3 详情 详情
Extended Information